New class of proteins allows breast cancer cells to evade tyrosine kinase inhibitors
Monday, August 13, 2012 - 14:00
in Health & Medicine
Aberrant regulation of cell growth pathways is required for normal cells to become cancerous, and in many types of cancer, cell growth is driven by a group of enzymes known as receptor tyrosine kinases. Two groups identify a pair of related oncogenes, FAM83A and B, which allow breast cancer cells to survive TKI treatment.